Neurizon inks $1.5M loan against R&D Tax Rebate
Neurizon Therapeutics (ASX:NUZ) retreated in intra-day trade on Wednesday after inking a non-dilutive loan agreement for $1.5 million to fund its current and future operations seeking to treat Huntington’s with its flagship drug NUZ-001.The funds in question are secured against it...
Corporate Spotlight
Not Yet Available
Are you a Company Director ?
Put your Investment Case to Hotcopper's 700K monthly unique visitors.
Latest Threads
Tag | Subject | ||||||
---|---|---|---|---|---|---|---|
CFW | Ann:AGM 2025 | 17/06/25 | 0 | 286 | |||
|
|||||||
CFW | Ann:Reinstatement to Official Quotation (Price Sensitive) | 21/05/25 | 0 | 319 | |||
|
|||||||
CFW | Ann:Notice of 2025 AGM | 19/05/25 | 0 | 337 | |||
|
|||||||
CFW | Ann:2024 audited financial statements (Price Sensitive) | 16/05/25 | 0 | 319 | |||
|
|||||||
CFW | Ann:Continuous Suspension from Official Quotation | 03/04/25 | 0 | 235 | |||
|
|||||||
CFW | Ann:Expected release date of FY2024 financial statements | 01/04/25 | 0 | 261 | |||
|
|||||||
CFW | Ann:Suspension from Official Quotation | 21/03/25 | 0 | 259 | |||
|
|||||||
CFW | Ann:Trading Halt Failure To Lodge Prelim Financials (Price Sensitive) | 19/03/25 | 0 | 299 | |||
|
See All Discussions
Timeline
![]() |
|
||||
![]() |
|
||||
![]() |
|
||||
![]() |
|
||||
![]() |
|
||||
![]() |
|
||||
View More |